引力傳媒(603598.SH):減持期屆滿 合眾創世未減持公司股份
格隆匯 1 月 22日丨引力傳媒(603598.SH)公佈,截至公吿披露日,北京合眾創世管理諮詢合夥企業(有限合夥)(“合眾創世”,原名:北京合眾創世管理諮詢有限公司)持有公司股份2000萬股,佔公司股份總數的7.39%。公司於2020年7月4日發佈了《股東減持股份計劃公吿》(公吿編號2020-052),合眾創世計劃於2020年7月27日-2021年1月22日,以大宗交易或集中競價等法律法規允許的方式(優先選擇大宗交易)減持其所持有的公司股份合計不超過500萬股。目前,此次減持計劃已屆滿,合眾創世未通過任何方式減持公司股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.